Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $68.35 Analyst target: $152.50 Upside: 123.12%
Sol-Gel Technologies Ltd., a specialty clinical-stage pharmaceutical company, is focused on developing and commercializing topical dermatological pharmaceuticals based on its Israel-patented microencapsulation delivery system. The company is headquartered in Ness Ziona, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.